Literature DB >> 22658432

The effect of topiramate plasma concentration on linguistic behavior, verbal recall and working memory.

S E Marino1, S V S Pakhomov, S Han, K L Anderson, M Ding, L E Eberly, D W Loring, C Hawkins-Taylor, J O Rarick, I E Leppik, J E Cibula, A K Birnbaum.   

Abstract

This is the first study of the effect of topiramate on linguistic behavior and verbal recall using a computational linguistics system for automated language and speech analysis to detect and quantify drug-induced changes in speech recorded during discourse-level tasks. Healthy volunteers were administered a single, 100-mg oral dose of topiramate in two double-blind, randomized, placebo-controlled, crossover studies. Subjects' topiramate plasma levels ranged from 0.23 to 2.81 μg/mL. We found a significant association between topiramate levels and impairment on measures of verbal fluency elicited during a picture description task, correct number of words recalled on a paragraph recall test, and reaction time recorded during a working memory task. Using the tools of clinical pharmacology and computational linguistics, we elucidated the relationship between the determinants of a drug's disposition as reflected in plasma concentrations and their impact on cognitive functioning as reflected in spoken language discourse.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22658432      PMCID: PMC3804073          DOI: 10.1016/j.yebeh.2012.04.120

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  41 in total

1.  Plasma concentration of topiramate correlates with cerebrospinal fluid concentration.

Authors:  J Christensen; C S Højskov; M Dam; J H Poulsen
Journal:  Ther Drug Monit       Date:  2001-10       Impact factor: 3.681

2.  Diagnostic Assessment of Childhood Apraxia of Speech Using Automatic Speech Recognition (ASR) Methods.

Authors:  John-Paul Hosom; Lawrence Shriberg; Jordan R Green
Journal:  J Med Speech Lang Pathol       Date:  2004-12

3.  Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy.

Authors:  D Blum; K Meador; V Biton; T Fakhoury; B Shneker; S Chung; K Mills; A Hammer; J Isojärvi
Journal:  Neurology       Date:  2006-08-08       Impact factor: 9.910

4.  A fast and sensitive liquid chromatographic-tandem mass spectrometric method for assay of lorazepam and application to pharmacokinetic analysis.

Authors:  Hailin Zhu; Jinwen Luo
Journal:  J Pharm Biomed Anal       Date:  2005-04-07       Impact factor: 3.935

5.  An analysis of connected speech samples of aphasic and normal speakers.

Authors:  K M Yorkston; D R Beukelman
Journal:  J Speech Hear Disord       Date:  1980-02

6.  Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy.

Authors:  N Fritz; S Glogau; J Hoffmann; M Rademacher; C E Elger; C Helmstaedter
Journal:  Epilepsy Behav       Date:  2005-05       Impact factor: 2.937

7.  Topiramate dose effects on cognition: a randomized double-blind study.

Authors:  D W Loring; D J Williamson; K J Meador; F Wiegand; J Hulihan
Journal:  Neurology       Date:  2010-12-09       Impact factor: 9.910

8.  Language Disturbances as Side Effects of Topiramate and Zonisamide Therapy.

Authors:  Linda M. Ojemann; George A. Ojemann; Carl B. Dodrill; Carol A. Crawford; Mark D. Holmes; Donald L. Dudley
Journal:  Epilepsy Behav       Date:  2001-12       Impact factor: 2.937

9.  Pharmacokinetics and metabolism of topiramate.

Authors:  B F Bourgeois
Journal:  Drugs Today (Barc)       Date:  1999-01       Impact factor: 2.245

10.  Cognitive profile of topiramate as compared with lamotrigine in epilepsy patients on antiepileptic drug polytherapy: relationships to blood serum levels and comedication.

Authors:  Edgar Kockelmann; Christian E Elger; Christoph Helmstaedter
Journal:  Epilepsy Behav       Date:  2004-10       Impact factor: 2.937

View more
  12 in total

1.  Using Automatic Speech Recognition to Assess Spoken Responses to Cognitive Tests of Semantic Verbal Fluency.

Authors:  Serguei V S Pakhomov; Susan E Marino; Sarah Banks; Charles Bernick
Journal:  Speech Commun       Date:  2015-09-28       Impact factor: 2.017

2.  Pharmacokinetic-Pharmacodynamic Modeling of Intravenous and Oral Topiramate and Its Effect on the Symbol-Digit Modalities Test in Adult Healthy Volunteers.

Authors:  Chay Ngee Lim; Angela K Birnbaum; Richard C Brundage; Ilo E Leppik; James C Cloyd; Annie Clark; Susan E Marino
Journal:  J Clin Pharmacol       Date:  2015-12-21       Impact factor: 3.126

3.  Pharmacokinetic-pharmacodynamic modelling of intravenous and oral topiramate and its effect on phonemic fluency in adult healthy volunteers.

Authors:  Ghada F Ahmed; Susan E Marino; Richard C Brundage; Serguei V S Pakhomov; Ilo E Leppik; James C Cloyd; Annie Clark; Angela K Birnbaum
Journal:  Br J Clin Pharmacol       Date:  2015-05       Impact factor: 4.335

4.  Long-lasting recognition memory impairment and alterations in brain levels of cytokines and BDNF induced by maternal deprivation: effects of valproic acid and topiramate.

Authors:  Rose Mary Carvalho Pinheiro; Maria Noêmia Martins de Lima; Bernardo Chaves Dávila Portal; Stefano Boemler Busato; Lucio Falavigna; Rafael Dal Ponte Ferreira; André Contri Paz; Bianca Wollenhaupt de Aguiar; Flávio Kapczinski; Nadja Schröder
Journal:  J Neural Transm (Vienna)       Date:  2014-09-03       Impact factor: 3.575

5.  Working Memory Capacity Is Negatively Associated with Memory Load Modulation of Alpha Oscillations in Retention of Verbal Working Memory.

Authors:  Zhenhong Hu; Christopher M Barkley; Susan E Marino; Chao Wang; Abhijit Rajan; Ke Bo; Immanuel Babu Henry Samuel; Mingzhou Ding
Journal:  J Cogn Neurosci       Date:  2019-08-16       Impact factor: 3.225

6.  Severity of Topiramate-Related Working Memory Impairment Is Modulated by Plasma Concentration and Working Memory Capacity.

Authors:  Samuel P Callisto; Sílvia M Illamola; Angela K Birnbaum; Christopher M Barkley; Sai Praneeth R Bathena; Ilo E Leppik; Susan E Marino
Journal:  J Clin Pharmacol       Date:  2020-04-16       Impact factor: 3.126

7.  Brain's compensatory response to drug-induced cognitive impairment.

Authors:  Immanuel Babu Henry Samuel; Christopher Barkley; Susan E Marino; Chao Wang; Sahng-Min Han; Angela K Birnbaum; Jean E Cibula; Mingzhou Ding
Journal:  J Clin Exp Neuropsychol       Date:  2018-05-02       Impact factor: 2.475

Review 8.  Refining the Benefit/Risk Profile of Anti-Epileptic Drugs in Headache Disorders.

Authors:  Michael J Marmura; Aliza S Kumpinsky
Journal:  CNS Drugs       Date:  2018-08       Impact factor: 5.749

9.  Use of an automated mobile application to assess effects of nicotine withdrawal on verbal fluency: A pilot study.

Authors:  Serguei V S Pakhomov; Wrenda Teeple; Anne M Mills; Michael Kotlyar
Journal:  Exp Clin Psychopharmacol       Date:  2016-08-15       Impact factor: 3.157

10.  Individual Differences in Working Memory Capacity Predict Topiramate-Related Cognitive Deficits.

Authors:  Christopher M Barkley; Zhenhong Hu; Ann M Fieberg; Lynn E Eberly; Angela K Birnbaum; Ilo E Leppik; Susan E Marino
Journal:  J Clin Psychopharmacol       Date:  2018-10       Impact factor: 3.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.